GSK Seeks Ax Of Zofran Birth Defect Claims

By Emily Field · June 11, 2019, 4:57 PM EDT

GlaxoSmithKline on Tuesday asked a Massachusetts federal judge to toss certain claims in multidistrict litigation alleging that its anti-nausea drug Zofran caused birth defects, saying that the patients hadn't shown the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Memorandum in Support of Motion

Case Information

Case Title

In Re: Zofran (Ondansetron)Products Liability Litigation

Case Number

Court

Massachusetts

Nature of Suit

Personal Injury: Health Care/Pharmaceutical Personal Injury Product Liability

Date Filed

October 13, 2015

Recent Articles By Emily

July 23, 2024
Meet The Lead Ozempic Lawyers
June 24, 2024
Ark. AG Sues Pharmacy Benefit Managers Over Opioids
May 03, 2024
6 States Strike $270M Opioid Deal With Amneal
April 17, 2024
FDA's Foot-Dragging On Menthol Ban Sparks Frustration
March 26, 2024
Opioid Public Nuisance Claims 'Unique,' Ohio High Court Told
March 25, 2024
What To Watch As Opioid Litigation Goes To Ohio High Court
March 11, 2024
FDA Seeks $7.2B For Fiscal Year 2025
March 07, 2024
Sens. Tell Stores To Get Illegal E-Cigs Off Their Shelves
February 27, 2024
10th Circ. Backs FDA E-Cigarettes Marketing Denial
February 14, 2024
NYC Sues Facebook, Social Media Cos. Over Teen Addiction